Primary Immuno-Deficiencies Affecting Specific Stages of the Immune Response

影响免疫反应特定阶段的原发性免疫缺陷

基本信息

项目摘要

This revised application for our new Program Project Grant brings together a group of investigators who are experts in the areas of molecular and cellular immunology and human and mouse genetics. We propose to study the role of single genes in the pathogenesis of X-linked Lymphoproliferative syndrome (XLP), Common variable immunodeficiency (CVID), Omenn syndrome and Severe Combined Immunodeficiencies (SCID) in an application, entitled: "Primary Immunodeficiencies Affecting Specific Stages of the Adaptive Immune Rresponse" Because of successful preliminary analyses of patient materials, exciting findings in genetically altered mice, this application seeks to define how mutations in the SH2D1A, SH2D1B/C, TACI, RAG-1/2, DNA Ligase IV or Cernunnos genes affect T and B cell development and T cell dependent and/or T cell-independent immunoglobulin responses. We will use our recently acquired insights into the causes of these diseases in the following four interlinked projects and an Administrative Core: Project #1 Role of the SAP (SH2D1A) gene in T cell-dependent antibody responses. Cox Terhorst, Beth Israel Deaconess Medical Center. Project #2 Role of in TACI mutations in Common Variable Immunodeficiency Raif Geha, Children's Hospital of Boston. Project #3 Gene knock-in models for Omenn syndrome and leaky SCID. Luigi Notarangelo, Children's Hospital of Boston. Project #4 Mouse Models of Severe Combined Immunodeficiencies. Fred Alt, Children's Hospital of Boston. Core A Administrative Core Cox Terhorst, Beth Israel Deaconess Medical Center. The outcomes of proposed studies should lead to better understanding of the complex and often alternate disease manifestations that are caused by mutations in a single gene. The results of these studies should suggest therapeutic strategies that can be applied to these PID patients and may unravel molecular and cellular mechanisms that are generally involved in immune dysregulation, autoimmunity and cancer.
这项修订后的新计划项目拨款申请汇集了一组研究人员

项目成果

期刊论文数量(28)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Functional overlaps between XLF and the ATM-dependent DNA double strand break response.
  • DOI:
    10.1016/j.dnarep.2014.01.010
  • 发表时间:
    2014-04
  • 期刊:
  • 影响因子:
    3.8
  • 作者:
    Kumar, Vipul;Alt, Frederick W.;Oksenych, Valentyn
  • 通讯作者:
    Oksenych, Valentyn
Immune deficiency caused by impaired expression of nuclear factor-kappaB essential modifier (NEMO) because of a mutation in the 5' untranslated region of the NEMO gene.
由于 NEMO 基因 5 非翻译区突变,核因子 kappaB 必需修饰物 (NEMO) 表达受损而导致免疫缺陷。
  • DOI:
    10.1016/j.jaci.2010.04.026
  • 发表时间:
    2010
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Mooster,JanaL;Cancrini,Caterina;Simonetti,Alessandra;Rossi,Paolo;DiMatteo,Gigliola;Romiti,MariaLuisa;DiCesare,Silvia;Notarangelo,Luigi;Geha,RaifS;McDonald,DouglasR
  • 通讯作者:
    McDonald,DouglasR
Heterozygosity for transmembrane activator and calcium modulator ligand interactor A144E causes haploinsufficiency and pneumococcal susceptibility in mice.
  • DOI:
    10.1016/j.jaci.2016.07.028
  • 发表时间:
    2017-04
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Jabara HH;Lee JJ;Janssen E;Ullas S;Liadaki K;Garibyan L;Benson H;Sannikova T;Bram R;Hammarstrom L;Cruz AC;Siegel R;Manis J;Malley R;Geha RS
  • 通讯作者:
    Geha RS
Whole-exome sequencing identifies tetratricopeptide repeat domain 7A (TTC7A) mutations for combined immunodeficiency with intestinal atresias.
  • DOI:
    10.1016/j.jaci.2013.06.013
  • 发表时间:
    2013-09
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Chen R;Giliani S;Lanzi G;Mias GI;Lonardi S;Dobbs K;Manis J;Im H;Gallagher JE;Phanstiel DH;Euskirchen G;Lacroute P;Bettinger K;Moratto D;Weinacht K;Montin D;Gallo E;Mangili G;Porta F;Notarangelo LD;Pedretti S;Al-Herz W;Alfahdli W;Comeau AM;Traister RS;Pai SY;Carella G;Facchetti F;Nadeau KC;Snyder M;Notarangelo LD
  • 通讯作者:
    Notarangelo LD
LPS-responsive beige-like anchor (LRBA) gene mutation in a family with inflammatory bowel disease and combined immunodeficiency.
  • DOI:
    10.1016/j.jaci.2012.05.043
  • 发表时间:
    2012-08
  • 期刊:
  • 影响因子:
    14.2
  • 作者:
    Alangari, Abdullah;Alsultan, Abdulrahman;Adly, Nouran;Massaad, Michel J.;Kiani, Iram Shakir;Aljebreen, Abdulrahman;Raddaoui, Emad;Almomen, Abdul-Kareem;Al-Muhsen, Saleh;Geha, Raif S.;Alkuraya, Fowzan S.
  • 通讯作者:
    Alkuraya, Fowzan S.
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

CORNELIS P TERHORST其他文献

CORNELIS P TERHORST的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('CORNELIS P TERHORST', 18)}}的其他基金

Primary Immuno-Deficiencies Affecting Specific Stages of the Immune Response
影响免疫反应特定阶段的原发性免疫缺陷
  • 批准号:
    8296689
  • 财政年份:
    2009
  • 资助金额:
    $ 173.37万
  • 项目类别:
Primary Immuno-Deficiencies Affecting Specific Stages of the Immune Response
影响免疫反应特定阶段的原发性免疫缺陷
  • 批准号:
    7560933
  • 财政年份:
    2009
  • 资助金额:
    $ 173.37万
  • 项目类别:
Role of SAP (SH2D1A) gene in T cell-dependent antibody response
SAP (SH2D1A) 基因在 T 细胞依赖性抗体反应中的作用
  • 批准号:
    7614096
  • 财政年份:
    2009
  • 资助金额:
    $ 173.37万
  • 项目类别:
Primary Immuno-Deficiencies Affecting Specific Stages of the Immune Response
影响免疫反应特定阶段的原发性免疫缺陷
  • 批准号:
    7882569
  • 财政年份:
    2009
  • 资助金额:
    $ 173.37万
  • 项目类别:
Primary Immuno-Deficiencies Affecting Specific Stages of the Immune Response
影响免疫反应特定阶段的原发性免疫缺陷
  • 批准号:
    8102821
  • 财政年份:
    2009
  • 资助金额:
    $ 173.37万
  • 项目类别:
IMMUNE
免疫
  • 批准号:
    7885362
  • 财政年份:
    2009
  • 资助金额:
    $ 173.37万
  • 项目类别:
Administrative Core
行政核心
  • 批准号:
    7614102
  • 财政年份:
    2009
  • 资助金额:
    $ 173.37万
  • 项目类别:
The Slamf3, Slamf5, and Slamf6 receptor-induced pathways to murine lupus
Slamf3、Slamf5 和 Slamf6 受体诱导的小鼠狼疮途径
  • 批准号:
    8345511
  • 财政年份:
    2006
  • 资助金额:
    $ 173.37万
  • 项目类别:
SLAM Gene Family Controlled Pathways to SLE
SLAM 基因家族控制 SLE 通路
  • 批准号:
    8339525
  • 财政年份:
    2006
  • 资助金额:
    $ 173.37万
  • 项目类别:
Administrative Core
行政核心
  • 批准号:
    8733827
  • 财政年份:
    2006
  • 资助金额:
    $ 173.37万
  • 项目类别:

相似海外基金

Characterization of Naturally Occurring Anti-Blood Group Antibody Formation
天然存在的抗血型抗体形成的表征
  • 批准号:
    9981001
  • 财政年份:
    2017
  • 资助金额:
    $ 173.37万
  • 项目类别:
Characterization of Naturally Occurring Anti-Blood Group Antibody Formation
天然存在的抗血型抗体形成的表征
  • 批准号:
    9751102
  • 财政年份:
    2017
  • 资助金额:
    $ 173.37万
  • 项目类别:
Characterization of Naturally Occurring Anti-Blood Group Antibody Formation
天然存在的抗血型抗体形成的表征
  • 批准号:
    9397073
  • 财政年份:
    2017
  • 资助金额:
    $ 173.37万
  • 项目类别:
Characterization of Naturally Occurring Anti-Blood Group Antibody Formation
天然存在的抗血型抗体形成的表征
  • 批准号:
    10223410
  • 财政年份:
    2017
  • 资助金额:
    $ 173.37万
  • 项目类别:
PREVENTING NEUTRALIZING ANTIBODY FORMATION IN MS PATIENTS WITH SC IFN-BETA (REBI
使用 SC IFN-β (REBI) 预防 MS 患者中和抗体形成
  • 批准号:
    7951676
  • 财政年份:
    2008
  • 资助金额:
    $ 173.37万
  • 项目类别:
PREVENTING NEUTRALIZING ANTIBODY FORMATION IN MS PATIENTS WITH SC IFN-β-AL
预防 SC IFN- 多发性硬化症患者中和抗体的形成
  • 批准号:
    7606036
  • 财政年份:
    2006
  • 资助金额:
    $ 173.37万
  • 项目类别:
IMMUNOLOGIC MECHANISM OF INHIBITOR ANTIBODY FORMATION IN HEMOPHILIA
血友病抑制剂抗体形成的免疫学机制
  • 批准号:
    7375053
  • 财政年份:
    2005
  • 资助金额:
    $ 173.37万
  • 项目类别:
IMMUNOLOGIC MECHANISM OF INHIBITOR ANTIBODY FORMATION IN HEMOPHILIA
血友病抑制剂抗体形成的免疫学机制
  • 批准号:
    7201220
  • 财政年份:
    2004
  • 资助金额:
    $ 173.37万
  • 项目类别:
Immunologic Mechanism of Inhibitor Antibody Formation in Hemophilia
血友病抑制剂抗体形成的免疫学机制
  • 批准号:
    6980810
  • 财政年份:
    2003
  • 资助金额:
    $ 173.37万
  • 项目类别:
INHIBITOR ANTIBODY FORMATION IN HEMOPHILIA AND VON WILLEBRAND'S DISEASE
血友病和冯·维勒布兰德病中的抑制剂抗体形成
  • 批准号:
    6419444
  • 财政年份:
    2000
  • 资助金额:
    $ 173.37万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了